Ingerø Reiten Investment Company AS has acquired 2,916,667 shares in Navamedic, representing an ownership of 26.84% in the company.
Navamedic is a distributor of health- and medical products in the Nordics, with a revenue of NOK 258m in 2017, and are listed on the Oslo Stock Exchange. Infima acted as advisor to Ingerø Reiten Investment Company on this transaction.